» Articles » PMID: 15939242

IV-IVC for Topically Applied Preparations--a Critical Evaluation

Overview
Specialty Pharmacology
Date 2005 Jun 9
PMID 15939242
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

In vitro-in vivo correlation (IV-IVC) is the relationship between an in vitro parameter (drug release or other rheological properties/measurement such as viscosity and spreadability) and an in vivo parameter (pharmacodynamic (PD) or dermatopharmacokinetic (DPK) or other measurement). In a true sense of correlation, in vitro measurement should predict in vivo performance of the product. For topically applied preparations, one of the in vitro measurements is the drug release from the formulation and in vivo measurement is the drug concentration in the stratum corneum, DPK or the PD measurements. The in vitro release of the drug is the property of the dosage form and is a measure of product quality and 'sameness', especially after certain Scale-UP and Post Approval Changes after initial drug approval. To obtain an IV-IVC for a topically applied drug product is a difficult challenge. However, some success has been achieved in showing a relationship between the drug release and PD and/or DPK measurement. Interestingly, one of the in vitro rheological properties was found to relate to the observed PD and DPK response for Clobetasol dipropionate products. Different rheological properties of the two formulation products explained the difference in DPK results obtained by two laboratories for the same tretinoin gel products. In the scientific arena, it is difficult to obtain a classical IV-IVC even for orally administered products and is more so difficult for topically administered drug products.

Citing Articles

Update on the advances and challenges in bioequivalence testing methods for complex topical generic products.

Alomari N, Alhussaini W Front Pharmacol. 2024; 15:1330712.

PMID: 38389924 PMC: 10881717. DOI: 10.3389/fphar.2024.1330712.


Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union.

Garcia-Arieta A, Gordon J, Gwaza L, Merino V, Mangas-Sanjuan V Pharmaceutics. 2023; 15(2).

PMID: 36839924 PMC: 9961670. DOI: 10.3390/pharmaceutics15020601.


In Vitro-In Vivo Correlations (IVIVC) for Predicting the Clinical Performance of Metronidazole Topical Creams Intended for Local Action.

Rath S, Kanfer I Pharmaceutics. 2023; 15(1).

PMID: 36678897 PMC: 9863435. DOI: 10.3390/pharmaceutics15010268.


Formulation and Evaluation of the In Vitro Performance of Topical Dermatological Products Containing Diclofenac Sodium.

Manian M, Jain P, Vora D, Banga A Pharmaceutics. 2022; 14(9).

PMID: 36145640 PMC: 9502351. DOI: 10.3390/pharmaceutics14091892.


Sensitivity of Different In Vitro Performance Tests and Their In Vivo Relevance for Calcipotriol/Betamethasone Ointment.

Habjanic N, Kos M, Kristan K Pharm Res. 2020; 37(3):52.

PMID: 32043181 DOI: 10.1007/s11095-020-2766-5.